This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights Procter & Gamble, Sony Group, Diageo, Toyota Motor and Intuitive Surgical
by Zacks Equity Research
Procter & Gamble, Sony Group, Diageo, Toyota Motor and Intuitive Surgical have been included in this Analyst Blog.
Top Analyst Reports for Procter & Gamble, Sony & Diageo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Sony Group Corporation (SONY), and Diageo plc (DEO).
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vinci Surgical System. Higher production costs are a woe.
Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?
by Zacks Equity Research
Investors need to pay close attention to Intuitive Surgical (ISRG) stock based on the movements in the options market lately.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $216.43, moving -0.62% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $227.64, moving -0.66% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $222.58, marking a +1.92% move from the previous day.
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vince Surgical System. Higher production costs are a woe.
3 Medical Product Stocks Set to Beat on Earnings This Season
by Trina Mukherjee
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.
The Zacks Analyst Blog Highlights Tesla, Medtronic, IBM, Lowe's Companies and Intuitive Surgical
by Zacks Equity Research
Tesla, Medtronic, IBM, Lowe's Companies and Intuitive Surgical have been included in this Analyst Blog.
Top Stock Reports for Tesla, Medtronic & IBM
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Medtronic plc (MDT), and International Business Machines Corporation (IBM).
The Zacks Analyst Blog Highlights Alcon, Zimmer Biomet, Cardiovascular Systems, Abbott and Intuitive Surgical
by Zacks Equity Research
Alcon, Zimmer Biomet, Cardiovascular Systems, Abbott and Intuitive Surgical have been included in this Analyst Blog.
Stock Market News for Apr 25, 2022
by Zacks Equity Research
U.S. stocks ended sharply lower on Friday, recording their worst day since 2020, as a fresh batch of corporate earnings and sharp near-term rate hike prospects led to massive selloffs.
3 Medical Product Stocks Poised to Beat This Earnings Season
by Urmimala Biswas
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
Intuitive Surgical (ISRG) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.
Intuitive Surgical, Inc. (ISRG) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 5.61% and 3.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Intuitive Surgical's (ISRG) Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $279.70 in the latest trading session, marking a -1.94% move from the prior day.
Earnings Preview: Intuitive Surgical, Inc. (ISRG) Q1 Earnings Expected to Decline
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $291.82, moving +1.09% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $304.44 in the latest trading session, marking a +0.81% move from the prior day.
Reasons to Retain Intuitive Surgical (ISRG) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $282.95, moving +1.84% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.74%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $273.69 in the latest trading session, marking a -0.74% move from the prior day.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $275.72 in the latest trading session, marking a -1.11% move from the prior day.